According to Pfizer's briefing document presented to the FDA last month, about 84% of the patients in their clinical trials experienced pain or swelling where the shot went in. About 62% experienced fatigue, 55% got headaches and about 38% experienced muscle pains. Smaller percentages of patients experienced chills, joint pain or fever.